Michal Abrahamowicz

Research Scientist, PhD



  • James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
  • Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre 

Research Interests

  • Biostatistics
  • Survival analysis
  • Pharmacoepidemiology
  • Clinical epidemiology
  • Epidemiologic methods
  • Longitudinal analysis
  • Non-communicable disease epidemiology

Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.

Learn more

His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).

Recent News Coverage

ARThritis Soirée goes virtual on May 27, 2021!

ARThritis Soirée goes virtual on May 27, 2021!Support arthritis research from the safety of your home. January 7, 2021 (Vancouver, BC) – Arthritis Research Canada’s signature event, the ARThritis Soirée, will celebrate its 8th year of raising awareness and funds for...

Keeping a healthy body weight key to curbing gout cases

Keeping a healthy body weight key to curbing gout cases January 4, 2021 (Vancouver) – A new Arthritis Research Canada study finds an estimated 77 per cent of gout cases could be avoided by controlling body weight and modifying specific lifestyle factors, including...

New Year, New Arthritis Research

As we leave 2020 behind, we face 2021 with a renewed sense of hope. Hope that vaccines put an end to the global pandemic. Hope that we see our friends and family again soon. Hope that life returns to normal. Hope is something people with arthritis know well, whether...

Arthritis patients see need for mental healthcare

Arthritis patients see need for mental healthcare December 11, 2020 (Vancouver) – A new Arthritis Research Canada study reveals individuals with arthritis have an increased perceived need for mental healthcare in comparison to the general population.The findings...